GlassScriptPhysician profile
Shreya Podder
NPI 1871085175
$39,339.61
in general payments reported to CMS, 2019-2025
27 companies · $32K in 2025
The $32K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $988 · 2023: $2,051 · 2024: $3,710 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $30K · Food and Beverage: $5,447 · Travel and Lodging: $2,275 · Education: $257 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $30,000.00 |
| Food and Beverage | $5,446.96 |
| Travel and Lodging | $2,275.25 |
| Education | $256.97 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,000.00 | 2025 | General - Therapies |
| Medical Device Business Services, INC. | $1,796.16 | 2024 | |
| Noah Medical Corporation | $1,721.45 | 2024-2025 | Galaxy |
| Astrazeneca Pharmaceuticals LP | $1,184.44 | 2022-2025 | Fasenra, Tagrisso, Tezspire |
| Medtronic, INC. | $980.03 | 2022-2023 | Illumisite |
| Pulmonx Corporation | $485.44 | 2022-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Intuitive Surgical, INC. | $445.68 | 2025 | |
| Genzyme Corporation | $367.20 | 2023-2025 | |
| Glaxosmithkline, LLC. | $322.76 | 2022-2025 | Nucala |
| Actelion Pharmaceuticals US, INC. | $300.85 | 2023-2024 | Opsumit, Uptravi |
| Elucent Medical | $250.00 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $230.35 | 2023-2025 | Dupixent |
| Alexion Pharmaceuticals, INC. | $221.93 | 2022-2023 | Soliris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.72 | 2021-2022 | |
| Ambu INC. | $180.18 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $157.66 | 2023 | |
| Philips North America LLC | $86.68 | 2022 | |
| United Therapeutics Corporation | $83.71 | 2023 | |
| Pinnacle Biologics, INC | $61.41 | 2025 | Photofrin |
| Olympus America INC. | $59.04 | 2024 | Single-Use Flexible Video Bronchoscope |
| Takeda Pharmaceuticals U.S.A., INC. | $44.60 | 2024 | Glassia |
| Insmed, INC. | $36.25 | 2025 | Arikayce |
| Cook Medical LLC | $32.22 | 2023-2024 | Blue Rhino, Melker |
| Ethicon INC. | $30.66 | 2024 | Monarch Platform |
| Electromed, INC. | $21.92 | 2022 | |
| Inogen, INC. | $18.51 | 2025 | |
| Genentech USA, INC. | $15.76 | 2024 | Actemra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shreya Podder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.